Kodiak Sciences Inc share price logo

Kodiak Sciences Inc

NASDAQ: KOD

Mid Cap

$43.95

+0.47

(+1.08%)

as on

Kodiak Sciences Inc Stock Performance

as on May 2, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $42.56
    $44.97
    downward going graph

    3.16%

    Downside

    2.32%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.81
    $47.84
    downward going graph

    93.61%

    Downside

    8.85%

    Upside

    downward going graph

Kodiak Sciences Inc share price movements today

Previous Close
$43.48
Open
$43.22
Volume
577.1K
Day's Low - High
$42.56 - $44.97
52 Week Low - High
$2.81 - $47.84

Kodiak Sciences Inc Historical Returns

1 Month Return
+ 8.2 %
3 Month Return
+ 82.33 %
1 Year Return
+ 815.83 %
3 Year Return
+ 922.33 %
5 Year Return
-63.62 %

Kodiak Sciences Inc Stock Fundamentals & Key Indicators

Check Kodiak Sciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7B

EPS (TTM)

-4.0573

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-216.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-149.49%

Kodiak Sciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kodiak Sciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$2.7B-63.62%NA0.00%
BUY$41.3B110.54%77.5712.55%
BUY$108.7B94.28%27.9332.94%
NA$32.7BNA118.495.37%
BUY$74.1B45.73%17.2729.65%

Stock Returns calculator for Kodiak Sciences Inc Stock including INR - Dollar returns

The Kodiak Sciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Kodiak Sciences Inc investment value today

Current value as on today

₹10,27,331

Returns

₹9,27,331

(+927.33%)

Returns from Kodiak Sciences Inc Stock

₹8,15,625 (+815.63%)

Dollar Impact

₹1,11,706 (+111.71%)

Analyst Recommendation on Kodiak Sciences Inc Stock

Based on 14 analysts

SELL

7.14%

Buy

35.71%

Hold

57.14%

Sell

Based on 14 analysts, 57.14% of analysts recommend a 'SELL' rating for Kodiak Sciences Inc. Average target price of $56.33

Kodiak Sciences Inc Share Price Target

Get share price movements and forecasts by analysts on Kodiak Sciences Inc.

What analysts predicted

21.98%UPSIDE

Target Price

$56.33

Current Price

$43.95

Analyzed by

14 Analysts

Target

$56.33

Kodiak Sciences Inc target price $56.33, a slight upside of 21.98% compared to current price of $43.95. According to 14 analysts rating.

Kodiak Sciences Inc Stock’s Investor Sentiment and Interest

Search interest for Kodiak Sciences Inc Stock has increased by 65% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:65% versus previous 30 day period

Kodiak Sciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
26
-
-
-
-
Gross Profit
-6
-6
-6
-6
-6
-6
-6
-6
-6
19
Operating Income
-54
-63
-46
-47
-46
-46
-57
-55
-62
-59
EBITDA
-43
-52
-36
-38
-37
-37
-50
-47
-54
-80
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
6
6
6
6
6
6
6
6
6
6
Income Before Tax
-50
-59
-43
-45
-43
-44
-57
-54
-61
-56
Income Tax Expense
-6
6
6
-
-43
-6
-
-
-
-
Net Income
-50
-59
-43
-45
-43
-44
-57
-54
-61
-56
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-165.47%
0.00%
0.00%
0.00%
0.00%

Kodiak Sciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-4
-8
-11
-25
-26
-
Operating Income
-17
-25
-26
-49
-136
-267
-341
-277
-186
-234
EBITDA
-16
-26
-35
-46
-128
-258
-322
-234
-149
-234
Interest Expense
0
1
5
0
0
0
0
0
-
-
Depreciation
-
0
0
0
4
8
11
25
26
26
Income Before Tax
-17
-27
-41
-47
-133
-266
-333
-260
-176
-229
Income Tax Expense
0
0
-9
0
2
0
7
-
-
-
Net Income
-17
-27
-41
-47
-133
-266
-333
-260
-176
-229
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Kodiak Sciences Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-59
-43
-45
-43
-44
-57
-54
-61
-56
Operating Cash Flow
-32
-39
-26
-21
-30
-29
-34
-32
-39
Investing Cash Flow
-27
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
-
0
0
0
0
177
Change in Cash
-60
-39
-26
-21
-29
-29
-34
-32
137

Kodiak Sciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-27
-41
-47
-133
-266
-333
-260
-176
-229
Operating Cash Flow
-17
-29
-39
-83
-182
-206
-154
-117
-136
Investing Cash Flow
0
0
-136
104
-38
-336
249
0
0
Financing Cash Flow
9
116
299
717
8
1
0
0
178
Change in Cash
-8
86
123
738
-212
-541
95
-117
41

Global Institutional Holdings in Kodiak Sciences Inc

Funds
Holdings
Adage Capital Partners Gp LLC
1.26%
D. E. Shaw & Co LP
1.14%
Nantahala Capital Management, LLC
1.12%
Perceptive Advisors LLC
1.02%
Point72 Asset Management, L.P.
4.65%

Kodiak Sciences Inc News & Key Events

  • img

    Today's Timeline - 26 March

    Thu, 04:36 PM

    -

    Kodiak Sciences stock hits 52-week high as plans for Biologics License Application advance, trading 45.5% above 20-day SMA.

    Fri, 06:51 AM

    -

    Kodiak Sciences surged 74.77% to $39.76, driven by significant efficacy results in diabetic retinopathy treatment.

Insights on Kodiak Sciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, KOD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, KOD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, KOD stock has moved up by 815.8%

About Kodiak Sciences Inc

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
OrganisationKodiak Sciences Inc
Headquarters1250 Page Mill Road, Palo Alto, CA, United States, 94304
IndustryBiotechnology
CEODr. Victor Perlroth M.D.
E-voting on sharesClick here to vote

Key Management of Kodiak Sciences Inc

Name

Title

Dr. Victor Perlroth M.D.

Co-Founder, Chairman, CEO & President

Mr. Wayne To M.Phil.

Chief Technology Officer

Dr. Dolly S. Chang M.D., M.P.H., Ph.D.

Chief Scientific Officer

Dr. Hong Liang Ph.D.

Senior Vice President of Development

Dr. Stephen Raillard Ph.D.

Senior Vice President of Chemical Development & Manufacturing

Ms. Almas Qudrat M.Sc.

Chief Quality Officer

Dr. J. Pablo Velazquez-Martin M.D.

Chief Medical Officer

Dr. Laurent Ducay Ph.D.

Senior VP of Biologics Development & Manufacturing

FAQs

What is Kodiak Sciences Inc share price today?

Kodiak Sciences Inc share price today is $43.95 as on at the close of the market. Kodiak Sciences Inc share today touched a day high of $44.97 and a low of $42.56.

What is the 52 week high and 52 week low for Kodiak Sciences Inc share?

Kodiak Sciences Inc share touched a 52 week high of $47.84 on and a 52 week low of $2.81 on . Kodiak Sciences Inc stock price today i.e. is closed at $43.95,which is 8.13% down from its 52 week high and 1464.00% up from its 52 week low.

What is Kodiak Sciences Inc's market capitalisation today?

Kodiak Sciences Inc market capitalisation is $0.00T as on .

How to invest in Kodiak Sciences Inc Stock (KOD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kodiak Sciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kodiak Sciences Inc Shares that will get you 0.0341 shares as per Kodiak Sciences Inc share price of $43.95 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Kodiak Sciences Inc Stock (KOD) from India?

Indian investors can start investing in Kodiak Sciences Inc (KOD) shares with as little as ₹94.91 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Kodiak Sciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Kodiak Sciences Inc share’s latest price of $43.95 as on May 2, 2026 at 1:29 am IST, you will get 0.2275 shares of Kodiak Sciences Inc. Learn more about fractional shares .

What are the returns that Kodiak Sciences Inc has given to Indian investors in the last 5 years?

Kodiak Sciences Inc stock has given -63.62% share price returns and 28.08% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?